Archive - February 2019
Cannabis Lollipop Can Be A Risk To People With Heart Ailment
A genomics and digital-led NHS is possible – but investment in staff essential
Gilead lead NASH drug flunks phase 3 test
Industry concerned about ‘rushed’ Brexit withdrawal legislation
SAW receives £1.5M funding for point-of-care diagnostics technology
Study says ‘Older people need better access to psychological therapies’
Gilead’s selonsertib fails in PhIII NASH trial
Yescarta rejected among other SMC decisions